Triple
T4132115
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | rVSV-ZEBOV |
E85063
|
entity |
| Predicate | subsequentlyDevelopedBy |
P17149
|
FINISHED |
| Object | Merck & Co. |
E106451
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Merck & Co. | Statement: [rVSV-ZEBOV, subsequentlyDevelopedBy, Merck & Co.]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Merck & Co. Context triple: [rVSV-ZEBOV, subsequentlyDevelopedBy, Merck & Co.]
-
A.
Merck & Co.
chosen
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
B.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
C.
GlaxoSmithKline
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
-
D.
Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
E.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: subsequentlyDevelopedBy Context triple: [rVSV-ZEBOV, subsequentlyDevelopedBy, Merck & Co.]
-
A.
developedAs
Indicates that one entity was created, designed, or evolved specifically to function as or replace another entity.
-
B.
alsoDevelopedIn
Indicates that something was additionally developed in another context, location, or environment beyond the primary one already specified.
-
C.
developedUnder
Indicates that something was created, produced, or brought into existence while being subject to the authority, guidance, or conditions imposed by a particular person, organization, regime, or framework.
-
D.
laterProducedBy
chosen
Indicates that something is produced or created by an entity at a later time than some referenced or implied production event.
-
E.
isDevelopedBy
Indicates that something (such as a product, project, or idea) is created, produced, or brought into existence through the work or effort of a particular developer or group of developers.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69aed935ccd881909dc61f81bcdb7a78 |
completed | March 9, 2026, 2:29 p.m. |
| NER | Named-entity recognition | batch_69af03a0f3408190adba7a8513bd3d12 |
completed | March 9, 2026, 5:30 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b57f2bb38c819090884069688063d2 |
completed | March 14, 2026, 3:30 p.m. |
| PD | Predicate disambiguation | batch_69af01883b6c8190a482ead589a131a5 |
completed | March 9, 2026, 5:21 p.m. |
Created at: March 9, 2026, 3:42 p.m.